Literature DB >> 2809005

Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy.

A L Caforio1, B Rossi, R Risaliti, G Siciliano, A Marchetti, C Angelini, F Crea, M Mariani, A Muratorio.   

Abstract

Abnormalities of skeletal muscle have been described in patients with dilated and hypertrophic cardiomyopathy. Eleven patients with dilated and eight with hypertrophic cardiomyopathy without overt symptomatic skeletal myopathy underwent extensive neuromuscular studies. Quantitative electromyography showed abnormal reduction of motor unit potential duration, indicative of myogenic myopathy, in four patients (36%) with dilated and in three (37%) with hypertrophic cardiomyopathy. Values were 21% to 40% (mean 28%) lower than those in age-matched normal control subjects. The presence of normal nerve conduction velocities and of normal motor unit fiber density in all patients indicated lack of neurogenic abnormalities. Skeletal muscle biopsy was performed in five patients with dilated and in four with hypertrophic cardiomyopathy. In all nine patients light and electron microscopy showed central hyporeactive cores, selective atrophy and mitochondrial abnormalities of type 1 fibers but not of type 2 fibers. The degree of impairment of left ventricular function in patients with electromyographic abnormalities was similar to that of those without (percent fractional shortening at two-dimensional echocardiography 21 +/- 9 versus 25 +/- 10, ejection fraction at angiography 39 +/- 13% versus 42 +/- 13% and left ventricular end-diastolic pressure 21 +/- 6 versus 21 +/- 8 mm Hg) as well as symptom duration (9 +/- 4 versus 12 +/- 8 months). Thus, subclinical electromyographic alterations indicative of myogenic myopathy are frequent in patients with dilated and hypertrophic cardiomyopathy and are unrelated to the degree of impairment of left ventricular function. The concomitant histologic alterations, characterized by selective type 1 atrophy, are similar to those observed in congenital and idiopathic myopathies, but different from those described in secondary heart failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809005     DOI: 10.1016/0735-1097(89)90383-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

Review 1.  Exercise training as therapy for chronic heart failure.

Authors:  N G Uren; D P Lipkin
Journal:  Br Heart J       Date:  1992-06

2.  Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice.

Authors:  Ping Li; Richard E Waters; Shelley I Redfern; Mei Zhang; Lan Mao; Brian H Annex; Zhen Yan
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Myopathy and hypertrophic cardiomyopathy with selective lysis of thick filaments.

Authors:  E Bertini; C Bosman; G Salviati; R Boldrini; S Servidei; E Ricci; F Del Nonno; M G Gagliardi; M Bevilacqua
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 4.  Peripheral circulatory adaptations to pump failure of the heart.

Authors:  H Drexler
Journal:  Br Heart J       Date:  1994-08

5.  Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction.

Authors:  Satoshi Araki; Yasuhiro Izumiya; Shinsuke Hanatani; Taku Rokutanda; Hiroki Usuku; Yuichi Akasaki; Toru Takeo; Naomi Nakagata; Kenneth Walsh; Hisao Ogawa
Journal:  Circ Heart Fail       Date:  2011-12-01       Impact factor: 8.790

6.  Pulmonary function and respiratory muscle strength in chronic heart failure: comparison between ischaemic and idiopathic dilated cardiomyopathy.

Authors:  M Daganou; I Dimopoulou; P A Alivizatos; G E Tzelepis
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

7.  Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis.

Authors:  G Vescovo; F Serafini; L Facchin; P Tenderini; U Carraro; L Dalla Libera; C Catani; G B Ambrosio
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

8.  Laing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsy.

Authors:  P J Lamont; B Udd; F L Mastaglia; M de Visser; P Hedera; T Voit; L R Bridges; V Fabian; A Rozemuller; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

9.  Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.

Authors:  L Fananapazir; M C Dalakas; F Cyran; G Cohn; N D Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

Review 10.  Exercise Dynamic of Patients with Chronic Heart Failure and Reduced Ejection Fraction.

Authors:  Sara Rovai; Irene Mattavelli; Elisabetta Salvioni; Ugo Corrà; Gaia Cattadori; Jeness Campodonico; Simona Romani; Piergiuseppe Agostoni
Journal:  Curr Cardiol Rep       Date:  2021-06-29       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.